Ratings Moves: ING,...
Health Care: Drugs
Merck & Co Inc (MRK: NYSE)
$47.16 -0.17 | -0.36%
05/24/13 - 04:00 PM ET
15.77M / 17.32M
Vol / Avg. Vol:47.05 / 47.33
Open / Prev. Close:46.60 - 47.16
Today's Range:37.02 - 48.79
52 Wk Range:15.61%
Performance YTD:TheStreet Rating:
Portfolios with MRK
- Portfolio NameUser Type
- User2013
- ContributorStocks Rising On Unusual Vo...
- UserJeeper Portfolio 1
- UserCapt Jer
- Userlennyvb Portfolio 1
- ContributorDogs of the Dow 2013
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserCovered Calls
- Contributor9 Dow Dividend Stocks With ...
Latest MRK Headlines from TheStreet
- Merck & Co Inc Stock Buy Recommendation Reiterated (MRK) 05.24.13 | 10:05 am
- Dow Today: Merck (MRK) Leads The Day Higher, International Business Machines (IBM) Lags 05.23.13 | 04:05 pm
- 5 Stocks Raising The Drugs Industry Higher 05.23.13 | 01:05 pm
- Merck & Co Inc (MRK): Today's Featured Drugs Laggard 05.22.13 | 05:05 pm
- Dow Today: Merck (MRK) Higher 05.22.13 | 12:05 pm
- Benefiting From the Rotation To Cyclicals
05.22.13 | 11:05 am - Allocate Assets to Buy-Rated Dow Stocks 05.22.13 | 08:05 am
- Merck Rises On Unusually High Volume (MRK) 05.21.13 | 03:05 pm
- Dow Today: Merck (MRK) Higher 05.21.13 | 12:05 pm
- Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons 05.20.13 | 08:05 pm
Press Releases for MRK
- Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. - PR Newswire 05.09.13 | 09:05 am
- Merck And Celebrity Chef Art Smith "Cook Up A Recipe" For Better Type 2 Diabetes Management - PR Newswire 05.07.13 | 08:05 am
- Merck Consumer Care Launches Health And Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their Families - PR Newswire 05.06.13 | 09:05 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Merck Announces FDA Acceptance Of Biologics License Application For Investigational Grass Pollen Allergy Immunotherapy Tablet - Business Wire 03.27.13 | 08:03 am
- Merck And Luminex Corporation Enter Agreement To Develop Companion Diagnostic To Support Investigational BACE Inhibitor Clinical Development Program For Alzheimer’s Disease - Business Wire 03.13.13 | 08:03 am
- Results From HPS2-THRIVE Study Of TREDAPTIVE™ (extended-release Niacin/laropiprant) Presented At American College Of Cardiology Scientific Sessions - Business Wire 03.09.13 | 12:03 pm
- Roger M. Perlmutter (Photo: Business Wire) - Business Wire 03.07.13 | 07:03 am
- Merck To Present At The 33rd Annual Cowen Health Care Conference - Business Wire 03.05.13 | 08:03 am
- Merck Announces Second-Quarter 2013 Dividend - Business Wire 02.26.13 | 02:02 pm
Partner Headlines for MRK
- Merck Enters into Strategic Deal - Analyst Blog - Zacks 05.23.13 | 12:05 am
- US doctors paid $1bn by top drug companies - Financial Times 05.22.13 | 07:05 pm
- Stock Market News for May 22, 2013 - Market News - Zacks 05.22.13 | 03:05 pm
- Market Close Report: NASDAQ Composite index closes at 3,502.12 up 5.69 points - NASDAQ 05.21.13 | 08:05 pm
- Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points - NASDAQ 05.20.13 | 08:05 pm
- Short Interest in Vertex Rises, in Celgene Falls - Benzinga 05.11.13 | 10:05 am
- GSK and Merck pioneer vaccine deal - Financial Times 05.09.13 | 05:05 pm
- 10 companies buying their own stock - MSN Money 05.09.13 | 04:05 pm
- Market Close Report: NASDAQ Composite index closes at 3,392.97 up 14.34 points - NASDAQ 05.06.13 | 08:05 pm
- Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13) - Seeking Alpha 05.05.13 | 06:05 am
